²é¿´: 2386  |  »Ø¸´: 18
±¾Ìû²úÉú 1 ¸ö ·­ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

ÑÛœI³ÉÔŠ

гæ (СÓÐÃûÆø)

[ÇóÖú] ÂÛÎÄÕªÒª£¬ÒѾ­google·­Ò룬Çë¸ßÈË°ïæÐÞ¸ÄÈóÉ«£¬²»Ê¤¸Ð¼¤

ÖÐÎÄÕªÒª£º
±¾ÎĵÄʵÑéÄ¿µÄ£º£¨1£©¿¼²ìÓ°Ïì·Ç°ÐÏòÐÔ¾ÛÈéËᣨPLA£©ÔØÒ©ÄÉÃ×Á£ÖƱ¸µÄ¹¤ÒÕÒòËØ£¬²¢¶Ô´¦·½½øÐй¤ÒÕÓÅ»¯£¬ÖƱ¸³öÁ£¾¶½ÏС¡¢ÔØÒ©ÂʺͰü·âÂʽϸߵÄPLAÔØÒ©ÄÉÃ×Á££»£¨2£©Ì½Ë÷²»Í¬·´Ó¦Ìõ¼þ¶Ô·Î°ÐÏòÅäÌå·Ö×ÓÒ¶ËᣨFA£©ºÍ͸Ã÷ÖÊËᣨHA£©Å¼ÁªÁ¿µÄÓ°Ï죬ȷ¶¨ÅäÌå·Ö×ÓµÄ×î¼ÑżÁª¹¤ÒÕ£»£¨3£©Í¨¹ýÄ£ÄâÌåÄÚ»·¾³¿¼²ì²»Í¬ÒòËضÔÄÉÃ×Á£ÊÍÒ©ÐÔÄܵÄÓ°Ï죬·ÖÎöÊÍÒ©»úÀí²¢½¨Á¢ºÏÊʵÄÊÍÒ©Ä£ÐÍ£¬ÎªÒ©ÎïÔÚÌåÄÚµÄҩЧѧÑо¿µì¶¨»ù´¡¡£²ÉÓõÄʵÑé·½·¨£º£¨1£©²ÉÓø´Èé·¨£¨W/O/W£©ºÍÈ黯ÈܼÁ»Ó·¢·¨£¨O/W£©·Ö±ðÖƱ¸°ÂɳÀû²¬PLAÄÉÃ×Á£¡¢¼ªÎ÷Ëû±õPLAÄÉÃ×Á£ºÍ×Ïɼ´¼PLAÄÉÃ×Á££¬¶ÔÁ½ÖÖÖƱ¸·½·¨ÖÐÓ°ÏìÄÉÃ×Á£Á£¾¶ºÍÔØÒ©ÂʵÄÒòËؽøÐе¥ÒòËØ¿¼²ì£¬É¸Ñ¡³ö½ÏºÃµÄˮƽÉè¼ÆÕý½»ÊµÑ飬ÓÅ»¯µÃµ½×î¼ÑÖƱ¸¹¤ÒÕ¡£Í¨¹ý͸Éäµç×ÓÏÔ΢¾µ£¨TEM£©ºÍZetaµçλ¼°¼¤¹âÁ£¶È·ÖÎöÒǶÔÄÉÃ×Á£ÐÎòºÍÁ£¾¶½øÐбíÕ÷£»£¨2£©¹ýõ£°·»¯·´Ó¦·Ö±ð½«FAºÍHAżÁªµ½PLAÔØÒ©ÄÉÃ×Á£±íÃ棬¿¼²ì²»Í¬·´Ó¦Ìõ¼þ¶ÔÅäÌåżÁªÁ¿µÄÓ°Ïì²¢ÕÒ³ö×î¼ÑżÁª¹¤ÒÕ¡£ºìÍâ¹âÆ×£¨IR£©±íÕ÷ÅäÌåżÁªÇé¿ö£¬Zetaµçλ¼°¼¤¹âÁ£¶È·ÖÎöÒǺÍɨÃèµç×ÓÏÔ΢¾µ£¨SEM£©¶ÔżÁªÅäÌåºóµÄÄÉÃ×Á£Á£¾¶ºÍÐÎò½øÐбíÕ÷£»£¨3£©¿¼²ì²»Í¬PHÖµ£¨PH=4.3¡¢PH=5.6ºÍPH=7.4£©¡¢²»Í¬ÔØÒ©ÂÊ£¨9.53%¡¢17.48%ºÍ26.37%£©ÒÔ¼°Å¼ÁªÅäÌå¶ÔÄÉÃ×Á£ÊÍÒ©ÐÔÄܵÄÓ°Ï죬²¢Ä£ÄâÈËÌåÄÚ²¿»·¾³½øÐÐÊÍÒ©ÐÐΪµÄÑо¿£¬·ÖÎöÿ¸ö½×¶ÎµÄÊÍÒ©»úÀí£¬ÄâºÏÎåÖÖ³£¼ûÒ©ÎïÄ£Ð͵ÄÇúÏß·½³Ì²¢Ñ¡Ôñ×î¼ÑÊÍÒ©Ä£ÐÍ¡£ÊµÑé½á¹û£º£¨1£©Í¨¹ýµ¥ÒòËØ¿¼²ìºÍÕý½»ÊÔÑéÉè¼ÆÈ·¶¨ÁËÖƱ¸ÈýÖÖÔØÒ©ÄÉÃ×Á£µÄ×î¼ÑÖƱ¸¹¤ÒÕ£¬ÔÚ×î¼ÑÖƱ¸Ìõ¼þÏÂÖƵõÄÔØÒ©ÄÉÃ×Á£ÔØÒ©ÂʺͰü·âÂÊ·Ö±ðΪ26.9%£¬66.5%£»27.4%£¬67.2%ºÍ30.3%£¬73.6%¡£ÄÉÃ×Á£±íÃæ¹â»¬Ô²Õû¡¢·ÖÉ¢ÐԺã¬Æ½¾ùÁ£¾¶·Ö±ðΪ110nm¡¢117nmºÍ125nm£¬ÇÒÁ£¾¶·Ö²¼·¶Î§½ÏÕ­£»£¨2£©ÓúìÍâ¹âÆ×£¨IR£©±íÕ÷ÄÉÃ×Á£±íÃæ·Ö×Ó»ùÍŵı仯£¬±íÃ÷FAºÍHA·Ö±ðͨ¹ýõ£°·¼ü×÷Óóɹ¦µÄżÁªµ½ÁËÄÉÃ×Á£±íÃ档ȷ¶¨ÁËFAºÍHAµÄ×î¼ÑżÁª¹¤ÒÕ£¬ÔÚ×î¼ÑżÁª·´Ó¦Ìõ¼þÏÂFAºÍHAµÄżÁªÁ¿·Ö±ðΪ0.0237¡Á10-3mol/gºÍ0.0178¡Á10-6mol/g¡£Á£¾¶·ÖÎö±íÃ÷FAżÁªÇ°ºóÄÉÃ×Á£Á£¾¶»ù±¾Îޱ仯£¬HA£¨Mr=300000£©Å¼ÁªºóÁ£¾¶ÓÉ122.2nmÔö³¤µ½131.3nm£¬±íÃ÷´ó·Ö×ÓÁ¿µÄHA¶ÔÁ£¾¶±ä»¯Ó°Ïì½Ï´ó¡£Í¨¹ý·Å´ó²»Í¬±¶ÊýµÄSEMÕÕƬ¿É¿´³öÅäÌåżÁªºóÄÉÃ×Á£·Ö²¼¾ùÔÈ£¬·ÖÉ¢ÐԽϺ㻣¨3£©ÄÉÃ×Á£ÊÍÒ©ËÙÂʺÍÀÛ»ýÊÍÒ©Á¿Ë³ÐòΪPH=4.3£¾PH=5.6£¾PH=7.4£¬ÇÒÔÚÒ»¶¨PH·¶Î§ÄÚËáÐÔԽǿÊÍÒ©ËÙÂʺÍÀÛ¼ÆÊÍ·ÅÁ¿Ô½¸ß£¬¸ßÔØÒ©ÂÊÄÉÃ×Á£ÔÚÏàͬ»·¾³ÏµÄÊÍÒ©ËÙÂʸßÓÚÖС¢µÍÔØÒ©ÂÊÄÉÃ×Á££¬FAżÁªºó¶ÔÄÉÃ×Á£ÊÍÒ©ÐÔÄÜ»ù±¾ÎÞÓ°Ï죬´ó·Ö×ÓµÄHAżÁªµ½ÄÉÃ×Á£±íÃæºóÊÍÒ©ËÙÂÊÃ÷ÏÔ½µµÍ¡£°ÐÏòPLAÔØÒ©ÄÉÃ×Á£Ä£ÄâÌåÄÚ»·¾³ÊÍÒ©±íÏÖ³öÁ¼ºÃµÄ»ºÊÍЧ¹û£¬ÄâºÏµÄFA/HA-PLAÔØÒ©ÄÉÃ×Á£µÄÊÍÒ©Ä£ÐÍ·Ö±ðΪInIn(1/(1-Q))=0.04633Int-1.03562ºÍ1-Q1/3=-0.01368t+1.04726¡£

google·­Ò룺
The purpose of this experiment: (1) examine the impact on non-target polylactic acid (PLA) drug-loaded nanoparticles preparation of process factors, and prescription process optimization, the preparation of a smaller particle size, drug loading and encapsulation efficiency. high PLA drug-loaded nanoparticles; (2) to explore different reaction conditions for lung targeting ligand folic acid (FA) and the amount of hyaluronic acid (HA) coupling to determine the optimal coupling of the ligand molecule process; (3) examine the impact of different factors on the drug release properties of nanoparticles by simulating the in vivo environment, analysis of the release mechanism and the establishment of appropriate release model, to lay the foundation for the drug in vivo pharmacodynamic studies. Experimental methods: (1) double emulsion (W / O / W) emulsion solvent evaporation method (O / W) Preparation of of oxaliplatin PLA nanoparticles, the gemcitabine PLA nanoparticles and paclitaxel PLA nanoparticles, two preparation methods of nanoparticles particle size and drug loading rate single factor study, filter out the good level orthogonal experiments to optimize the best preparation process. By transmission electron microscopy (TEM) and Zeta potential and laser particle size analyzer nanoparticle morphology and particle size characterization; (2) Over amidation reaction of the FA and HA coupling to the surface of the PLA drug-loaded nanoparticles investigated The reaction conditions on the amount of ligand coupled and find out the best coupling process. Infrared spectroscopy (IR) characterization of ligand coupling, zeta potential and laser particle size analyzer and scanning electron microscope (SEM) coupled ligand nanoparticle size and morphology were characterized; (3) study at different pH values ​​( pH = 4.3 and pH = 5.6 and pH = 7.4), different drug loading rate (9.53%, 17.48% and 26.37%, respectively), and the of coupling ligands on the drug release properties of nanoparticles and simulate the body's internal environment release behavior research, analysis of each stage of the release mechanism, fitting the curve equation model of five common drugs and select the best drug delivery model. Results: (1) single factor and orthogonal design to determine optimal preparation prepared three kinds of drug-loaded nanoparticles, drug loading and encapsulation efficiency obtained in the best preparation conditions of drug-loaded nanoparticles were 26.9%, 66.5%; 27.4%, 67.2% and 30.3%, 73.6%, respectively. Nanoparticle surface is smooth and round, good dispersion, the average particle size of 110nm, 117nm and 125 nm, and the particle size distribution is narrow; (2) changes in the nanoparticle surface molecular groups characterized by infrared spectroscopy (IR), indicating that the HA and FA were successful through the amide key role of coupling to the surface of the nanoparticles. The FA and HA coupling process, under the reaction conditions in the top coupling a coupling amount of FA and HA were 0.0237 ¡Á 10-3mol / g and 0.0178 ¡Á 10 6 mol / g. The particle size analysis showed that the nanoparticles before and after the FA coupled particle size did not change the basic HA (Mr = 300000) the coupled particle size growth from 122.2nm to 131.3nm, indicating that the high molecular weight HA greater impact on particle size change. As can be seen by SEM photographs zoom multiples ligand coupled nanoparticle distribution, good dispersion; (3) nanoparticles release rate and the cumulative amount of drug release order for pH = 4.3 pH = 5.6> pH = 7.4, and the stronger the acidity within a certain pH range higher release rate and cumulative release, high drug loading nanoparticles release rate is higher than in the same environment in low drug loading nanoparticles FA coupling basically no effect on the drug release properties of nanoparticles, macromolecular HA coupled to the surface of the nanoparticles, drug release rate was significantly lower. Exhibit good release effect targeting PLA drug-loaded nanoparticles simulated environment in vivo release fitting FA / HA-PLA model the release of the drug-loaded nanoparticles were ININ (1 / (1-Q)) = 0.04633 Int-1.03562 and 1-Q1 / 3 =-0.01368t +1.04726-.
ÇàÇà×ÓñÆ£¬ÓÆÓÆÎÒÐÄ...
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

huangzx1314

½û³æ (ÖªÃû×÷¼Ò)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ...
ÑÛœI³ÉÔŠ: ½ð±Ò+50, ·­ÒëEPI+1, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, лл£¬ÓõÄÅ®ÅóÓѵĺŠ2013-04-22 08:48:59
ÑÛœI³ÉÔŠ: ½ð±Ò+50, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, ÔٴθÐл 2013-04-22 09:35:19
²ÉÓõÄʵÑé·½·¨£º£¨1£©²ÉÓø´Èé·¨£¨W/O/W£©ºÍÈ黯ÈܼÁ»Ó·¢·¨£¨O/W£©·Ö±ðÖƱ¸°ÂɳÀû²¬PLAÄÉÃ×Á£¡¢¼ªÎ÷Ëû±õPLAÄÉÃ×Á£ºÍ×Ïɼ´¼PLAÄÉÃ×Á££¬¶ÔÁ½ÖÖÖƱ¸·½·¨ÖÐÓ°ÏìÄÉÃ×Á£Á£¾¶ºÍÔØÒ©ÂʵÄÒòËؽøÐе¥ÒòËØ¿¼²ì£¬É¸Ñ¡³ö½ÏºÃµÄˮƽÉè¼ÆÕý½»ÊµÑ飬ÓÅ»¯µÃµ½×î¼ÑÖƱ¸¹¤ÒÕ¡£Í¨¹ý͸Éäµç×ÓÏÔ΢¾µ£¨TEM£©ºÍZetaµçλ¼°¼¤¹âÁ£¶È·ÖÎöÒǶÔÄÉÃ×Á£ÐÎòºÍÁ£¾¶½øÐбíÕ÷£»

Experimental methods: (1) both double emulsion (W/O/W) and emulsion solvent evaporation method (O/W) were employed for Preparation of oxaliplatin PLA nanoparticles, the gemcitabine PLA nanoparticles and paclitaxel PLA nanoparticles, the influence factor of two preparation methods on nanoparticles size and drug loading rate were investigated via  single factor investigation, the best orthogonal experiment design achieved, and the preparation process was optimized. nanoparticle morphology and nanoparticle size were characterized through transmission electron microscopy(TEM) and Zeta potential characterization and laser particle size analyzer;

¹ýõ£°·»¯·´Ó¦·Ö±ð½«FAºÍHAżÁªµ½PLAÔØÒ©ÄÉÃ×Á£±íÃ棬¿¼²ì²»Í¬·´Ó¦Ìõ¼þ¶ÔÅäÌåżÁªÁ¿µÄÓ°Ïì²¢ÕÒ³ö×î¼ÑżÁª¹¤ÒÕ¡£ºìÍâ¹âÆ×£¨IR£©±íÕ÷ÅäÌåżÁªÇé¿ö£¬Zetaµçλ¼°¼¤¹âÁ£¶È·ÖÎöÒǺÍɨÃèµç×ÓÏÔ΢¾µ£¨SEM£©¶ÔżÁªÅäÌåºóµÄÄÉÃ×Á£Á£¾¶ºÍÐÎò½øÐбíÕ÷£»

FA and HA were coupled on the surface of the PLA drug-loaded nanoparticles through amidation reaction, the optimal amidation process was determined through analysis of the influence of various reaction condition on the amount of ligand coupling. Ligand coupling was characterized though Infrared spectroscopy (IR), nanoparticle size and nanoparticle morphology were characterized through scanning electron microscopy(SEM) and Zeta potential characterization and laser particle size analyzer

½ñÌì±È½ÏÍíÁË£¬Ã÷ÌìÔÙ°ïÄãÕûÒ»ÏÂʣϵģ¬ÎÒÕûÀíµÄ²»Ò»¶¨ÍêÈ«ÕýÈ·£¬½ö¹©Â¥Ö÷²Î¿¼£¬²»¹ýÓиö±ð¾ä×ÓÂ¥Ö÷µÄººÓïÒ²´æÔÚÒ»¶¨µÄÎÊÌ⣬ϣÍûÂ¥Ö÷ÔÙ¶à¶Á¼¸±é£¬ÍêÉÆһϡ£
8Â¥2013-04-22 00:06:31
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

huangzx1314

½û³æ (ÖªÃû×÷¼Ò)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

(3) ¿¼²ì²»Í¬PHÖµ£¨PH=4.3¡¢PH=5.6ºÍPH=7.4£©¡¢²»Í¬ÔØÒ©ÂÊ£¨9.53%¡¢17.48%ºÍ26.37%£©ÒÔ¼°Å¼ÁªÅäÌå¶ÔÄÉÃ×Á£ÊÍÒ©ÐÔÄܵÄÓ°Ï죬²¢Ä£ÄâÈËÌåÄÚ²¿»·¾³½øÐÐÊÍÒ©ÐÐΪµÄÑо¿£¬·ÖÎöÿ¸ö½×¶ÎµÄÊÍÒ©»úÀí£¬ÄâºÏÎåÖÖ³£¼ûÒ©ÎïÄ£Ð͵ÄÇúÏß·½³Ì²¢Ñ¡Ôñ×î¼ÑÊÍÒ©Ä£ÐÍ¡£

(3) the influence of pH values (pH = 4.3, 5.6 and 7.4), drug loading rates (9.53%, 17.48%, and 26.37%), and the of coupling ligands on the drug release properties of nanoparticles were studied, and the internal environment release behavior of body was simulated, the release mechanism in different stage was analysed, the best drug delivery model was selected through fitting the curve equation model of five kinds of common drugs.

ʵÑé½á¹û£º£¨1£©Í¨¹ýµ¥ÒòËØ¿¼²ìºÍÕý½»ÊÔÑéÉè¼ÆÈ·¶¨ÁËÖƱ¸ÈýÖÖÔØÒ©ÄÉÃ×Á£µÄ×î¼ÑÖƱ¸¹¤ÒÕ£¬ÔÚ×î¼ÑÖƱ¸Ìõ¼þÏÂÖƵõÄÔØÒ©ÄÉÃ×Á£ÔØÒ©ÂʺͰü·âÂÊ·Ö±ðΪ26.9%£¬66.5%£»27.4%£¬67.2%ºÍ30.3%£¬73.6%¡£ÄÉÃ×Á£±íÃæ¹â»¬Ô²Õû¡¢·ÖÉ¢ÐԺã¬Æ½¾ùÁ£¾¶·Ö±ðΪ110nm¡¢117nmºÍ125nm£¬ÇÒÁ£¾¶·Ö²¼·¶Î§½ÏÕ­£»

Results: (1) the best fabrication process of three kinds of drug-loaded nanoparticles were determined through the investigation of single factor and orthogonal design, drug loading rates of the three kinds of drug-loaded nanoparticles obtained in the optimal preparation process were 26.9%, 27.4%, and 30.3%, respectively, while the encapsulation efficiency of that were 66.5%, 67.2%, and 73.6%. The average diameter of obtained nanoparticles were 110nm, 117nm, and 125 nm, respectively, with smooth and rounded morphology, good dispersion, and narrow particle size distribution.

(2) ÓúìÍâ¹âÆ×£¨IR£©±íÕ÷ÄÉÃ×Á£±íÃæ·Ö×Ó»ùÍŵı仯£¬±íÃ÷FAºÍHA·Ö±ðͨ¹ýõ£°·¼ü×÷Óóɹ¦µÄżÁªµ½ÁËÄÉÃ×Á£±íÃ档ȷ¶¨ÁËFAºÍHAµÄ×î¼ÑżÁª¹¤ÒÕ£¬ÔÚ×î¼ÑżÁª·´Ó¦Ìõ¼þÏÂFAºÍHAµÄżÁªÁ¿·Ö±ðΪ0.0237¡Á10-3mol/gºÍ0.0178¡Á10-6mol/g¡£Á£¾¶·ÖÎö±íÃ÷FAżÁªÇ°ºóÄÉÃ×Á£Á£¾¶»ù±¾Îޱ仯£¬HA£¨Mr=300000£©Å¼ÁªºóÁ£¾¶ÓÉ122.2nmÔö³¤µ½131.3nm£¬±íÃ÷´ó·Ö×ÓÁ¿µÄHA¶ÔÁ£¾¶±ä»¯Ó°Ïì½Ï´ó¡£Í¨¹ý·Å´ó²»Í¬±¶ÊýµÄSEMÕÕƬ¿É¿´³öÅäÌåżÁªºóÄÉÃ×Á£·Ö²¼¾ùÔÈ£¬·ÖÉ¢ÐԽϺã»

The change of molecular groups on nanoparticle surface were characterized by infrared spectroscopy (IR), the study results indicated that HA and FA groups were successfully coupled to the nanoparticles with the amide bonds. The coupling amount of FA and HA under the optimal process, which was decided in our experiment, were 0.0237 ¡Á 10-3mol/g and 0.0178 ¡Á 10 6 mol/g. The results of particle size analysis showed that the size of nanoparticles were same before and after the FA coupling, while the particles size increased from 122.2nm to 131.3nm with the HA(Mr=300000) coupling, which indicated that the high molecular weight HA has a great impact on particle size. The SEM photographs with different magnification showed the uniform distribution and good dispersion of ligand coupled nanoparticle  

£¨3£©ÄÉÃ×Á£ÊÍÒ©ËÙÂʺÍÀÛ»ýÊÍÒ©Á¿Ë³ÐòΪPH=4.3£¾PH=5.6£¾PH=7.4£¬ÇÒÔÚÒ»¶¨PH·¶Î§ÄÚËáÐÔԽǿÊÍÒ©ËÙÂʺÍÀÛ¼ÆÊÍ·ÅÁ¿Ô½¸ß£¬¸ßÔØÒ©ÂÊÄÉÃ×Á£ÔÚÏàͬ»·¾³ÏµÄÊÍÒ©ËÙÂʸßÓÚÖС¢µÍÔØÒ©ÂÊÄÉÃ×Á££¬FAżÁªºó¶ÔÄÉÃ×Á£ÊÍÒ©ÐÔÄÜ»ù±¾ÎÞÓ°Ï죬´ó·Ö×ÓµÄHAżÁªµ½ÄÉÃ×Á£±íÃæºóÊÍÒ©ËÙÂÊÃ÷ÏÔ½µµÍ¡£°ÐÏòPLAÔØÒ©ÄÉÃ×Á£Ä£ÄâÌåÄÚ»·¾³ÊÍÒ©±íÏÖ³öÁ¼ºÃµÄ»ºÊÍЧ¹û£¬ÄâºÏµÄFA/HA-PLAÔØÒ©ÄÉÃ×Á£µÄÊÍÒ©Ä£ÐÍ·Ö±ðΪInIn(1/(1-Q))=0.04633Int-1.03562ºÍ1-Q1/3=-0.01368t+1.04726¡£

Drug release rate and the cumulative amount of drug release of nanoparticles decreased with the increasing pH values(4.3, 5.6, and 7.4), and the stronger acidity within a certain pH range leads to a higher release rate and cumulative release, release rate of high drug loading nanoparticles is higher than that in middle and low drug loading nanoparticles in the same conditions, the influence of FA coupling on the drug release properties of nanoparticles was little, drug release rate was significantly reduced after macromolecular HA coupled to the surface of the nanoparticles. targeting PLA drug-loaded nanoparticles exhibited good controlled-release effect in simulated environment of body, the fitted FA and HA-PLA drug release model of the drug-loaded nanoparticles were ININ (1 / (1-Q)) = 0.04633 Int-1.03562 and 1-Q1 / 3 =-0.01368t +1.04726, respectively.
12Â¥2013-04-22 09:18:51
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

huangzx1314

½û³æ (ÖªÃû×÷¼Ò)

ÒýÓûØÌû:
10Â¥: Originally posted by yerufeng20 at 2013-04-22 08:46:56
ллÁË°¡£¬ÎÒººÓïûѧºÃ£¬Ó¢ÓïѧµÄ¾Í¸ü²îÁË£¬°¦£¬ºÜÆæ¹ÖµÄ£¬¶ÔÓïÑÔû¸Ð¾õ£¬Âé·³ÄúÔÙ¸øÎÒ¿´¿´Ê£Ïµİɣ¬EPIÖ»ÄܸøÒ»¸öÈËÂð£¿Äú°ïÎÒ·­ÒëµÄ¶à£¬ºÇºÇ£¬ÏȸøÄú°É...

ÒÑ·­£¬Ë®Æ½Ò»°ã£¬½ö¹©Â¥Ö÷²Î¿¼

°æÖ÷£¬¹ÒÅƹҵIJ»ÉÙ°¡£¬°ÑÄÇÅÆ×Ó¸øÎÒ¸ãÒ»¸öߣ¬ºÇºÇ~~~
13Â¥2013-04-22 09:22:10
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

huangzx1314

½û³æ (ÖªÃû×÷¼Ò)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

ÒýÓûØÌû:
14Â¥: Originally posted by ÑÛœI³ÉÔŠ at 2013-04-22 09:33:31
ÅÆÅÆûÓ𡣬ÕæÏÛĽÄãµÄÓ¢Óïˮƽ°¡...

ÆäʵÎÒµÄÓ¢ÓïÏ¡À𡣬ºÇºÇ£¬»¹ÇëÂ¥Ö÷×Ô¼ºÔںúÿ´¿´~~
15Â¥2013-04-22 09:37:25
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌøת ÎÒÒª¶©ÔÄÂ¥Ö÷ ÑÛœI³ÉÔŠ µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍƼö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[½Ìʦ֮¼Ò] ÔÚ´óµØÉÏÎÒÃÇÖ»¹ýÒ»Éú---¿´ÍêÎҵİ¢ÀÕÌ©ÉÏÍ·Á˺ü¸Ì죬Íê½áÄÇÌìÍíÉϼ¸ºõʧÃß +11 ˲ϢÓîÖæ 2024-05-27 13/650 2024-06-01 22:15 by otani
[½Ìʦ֮¼Ò] Ë«·Ç±¾¿Æ±ÏÒµÂÛÎÄ£¬ÆøÈË +7 ºÓÎ÷Ò¹ÀÉ 2024-05-27 12/600 2024-06-01 22:12 by iwdw2012
[»ù½ðÉêÇë] »¯Ñ§B02¿ÚÇà»ù ´ú±í×÷¶¼ÊÇʲôˮƽµÄ£¿Ïò´óÀÐÇóÖú +8 arthas_007 2024-06-01 10/500 2024-06-01 22:05 by photocatalysis
[»ù½ðÉêÇë] »¯Ñ§¿ÚB0109(¸ß·Ö×ӺϳÉ)£¬ÄÃÇàÄê»ù½ðÒ»°ãÐèÒªÔõÑùµÄÎÄÕÂˮƽ£¿ +13 salmon95 2024-05-30 22/1100 2024-06-01 21:22 by salmon95
[½Ìʦ֮¼Ò] Ñо¿ÉúÔÚ±ÏÒµ´ð±çʱ¹ÒÁË£¬Òź¶ +10 spacr2022 2024-05-27 13/650 2024-06-01 17:45 by keyaner23
[˶²©¼ÒÔ°] ¸÷λͬѧÄÜ·ñ·ÖÏíÒ»ÏÂʵÑéÊÒµÄѧÉúÀÍÎñ·¢·Å±ê׼ѽ£¿ +18 ma3252788 2024-05-30 18/900 2024-06-01 17:02 by ÂäÓê·ç˪
[˶²©¼ÒÔ°] ÂÛ´ó¼Ò¶Ô6070ºóÆÕͨ½ÌÊÚµ¼Ê¦µÄ¿´·¨ +6 SNaiL1995 2024-05-28 10/500 2024-06-01 16:55 by ÀºÇòÒ×·É
[»ù½ðÉêÇë] ÊýÀíµÄÈ˲Ŵð±ç֪ͨ·¢ÁËÂð +7 yzy3327 2024-05-30 7/350 2024-06-01 09:15 by Èö¹þÀ­Î÷²¿
[˶²©¼ÒÔ°] ÌÖÑá¾Æ×ÀÎÄ»¯ +6 hahamyid 2024-05-31 6/300 2024-06-01 09:03 by lizhiweiouc
[¿¼²©] ÇóÉúÎïѧµÄ²©µ¼ÊÕÁô +4 É격³É¹¦¹¦³É²©É 2024-06-01 4/200 2024-06-01 08:01 by ÆðÃû×Ö°¥
[Óлú½»Á÷] ±½·ÓºÍȲäå·´Ó¦³ÉÃÑ 6+3 TONGMEIMEI 2024-05-26 12/600 2024-05-31 14:41 by TONGMEIMEI
[»ù½ðÉêÇë] ÈëÖ°¸ßУ3Äê·¢±í10+SCI£¬¾¡ÈËÊÂÌýÌìÃü +29 kaoyan250 2024-05-27 40/2000 2024-05-31 08:44 by Xiaolin81
[µç»¯Ñ§] ÓÐ﮽ðÊôÈí°üµç³Ø´ú¹¤¹«Ë¾´ú×öÈí°üÂï +5 yyywj995 2024-05-26 6/300 2024-05-30 08:33 by ÄÇÄêµÄ¾É³Ç
[ÂÛÎÄͶ¸å] ¡¶¿ØÖÆÀíÂÛÓëÓ¦Óá·ÆÚ¿¯ÊÕ°æÃæ·ÑÂ𣿠+4 ygj2015 2024-05-29 4/200 2024-05-30 06:59 by nono2009
[»ù½ðÉêÇë] ÐÅϢѧ²¿º¯ÆÀ½áÊøÁËÂ𣿠+6 ducan21 2024-05-28 7/350 2024-05-29 12:10 by WORLD0256
[»ù½ðÉêÇë] Èç¹ûÄúÊǹú×ÔÈ»ÆÀÉóר¼Ò +3 ¶¡ÏãÔ°ÕË»§ 2024-05-28 3/150 2024-05-29 06:44 by gaohui8888
[ÂÛÎÄͶ¸å] EIѧ±¨£¬Ò»Éó·µÐÞºó£¬ÎªÉ¶²»ÔÙËÍÉó£¬Ö±½ÓÖÕÉóÖÐ? +4 qweasd12345 2024-05-27 6/300 2024-05-29 00:02 by dut_ameng
[ÂÛÎÄͶ¸å] EIÆÚ¿¯Éó¸åÈËÓÊÏäÎÊÌâ 5+3 shierÂèÂè 2024-05-27 4/200 2024-05-28 14:53 by topedit
[˶²©¼ÒÔ°] ÎÒÊǺÜÀíÏ뻯һÈË +6 hahamyid 2024-05-26 6/300 2024-05-27 18:13 by ´ó·ÉÓãÓãÓã
[˶²©¼ÒÔ°] ÖÜÈÕ +6 1¼ÓÓÍŶ°ô 2024-05-26 9/450 2024-05-27 10:30 by hahamyid
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û